Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 3/2024

Open Access 01-03-2024 | NSCLC | Research

Influence of abdominal fat distribution and inflammatory status on post-operative prognosis in non-small cell lung cancer patients: a retrospective cohort study

Authors: Mengtian Ma, Muqing Luo, Qianyun Liu, Dong Zhong, Yinqi Liu, Kun Zhang

Published in: Journal of Cancer Research and Clinical Oncology | Issue 3/2024

Login to get access

Abstract

Purpose

To evaluate the influence of visceral fat area (VFA), subcutaneous fat area (SFA), the systemic immune-inflammation index (SII) and total inflammation-based systemic index (AISI) on the postoperative prognosis of non-small cell lung cancers (NSCLC) patients.

Methods

266 NSCLC patients received surgery from two academic medical centers were included. To assess the effect of abdominal fat measured by computed tomography (CT) imaging and inflammatory indicators on patients’ overall survival (OS) and progression-free survival (PFS), Kaplan–Meier survival analysis and Cox proportional hazards models were used.

Results

Kaplan–Meier analysis showed the OS and PFS of patients in high-VFA group was better than low-VFA group (p < 0.05). AISI and SII were shown to be risk factors for OS and PFS (p < 0.05) after additional adjustment for BMI (Cox regression model II). After further adjustment for VFA (Cox regression model III), low-SFA group had longer OS (p < 0.05). Among the four subgroups based on VFA (high/low) and SFA (high/low) (p < 0.05), the high-VFA & low-SFA group had the longest median OS (108 months; 95% CI 74–117 months) and PFS (85 months; 95% CI 65–117 months), as well as the lowest SII and AISI (p < 0.05). Low-SFA was a protective factor for OS with different VFA stratification (p < 0.05).

Conclusion

VFA, SFA, SII and AISI may be employed as significant prognostic markers of postoperative survival in NSCLC patients. Moreover, excessive SFA levels may encourage systemic inflammation decreasing the protective impact of VFA, which may help to provide targeted nutritional support and interventions for postoperative NSCLC patients with poor prognosis.
Literature
go back to reference Alduais Y, Zhang H, Fan F, Chen J, Chen B (2023) Non-small cell lung cancer (NSCLC): a review of risk factors, diagnosis, and treatment. Medicine (baltimore) 102(8):e32899PubMed Alduais Y, Zhang H, Fan F, Chen J, Chen B (2023) Non-small cell lung cancer (NSCLC): a review of risk factors, diagnosis, and treatment. Medicine (baltimore) 102(8):e32899PubMed
go back to reference Ashton E, Arrondeau J, Jouinot A, Boudou-Rouquette P, Hirsch L, Huillard O, Ulmann G, Lupo-Mansuet A, Damotte D, Wislez M, Alifano M et al (2023) Impact of sarcopenia indexes on survival and severe immune acute toxicity in metastatic non-small cell lung cancer patients treated with PD-1 immune checkpoint inhibitors. Clin Nutr (edinburgh, Scotland) 42(6):944–953 Ashton E, Arrondeau J, Jouinot A, Boudou-Rouquette P, Hirsch L, Huillard O, Ulmann G, Lupo-Mansuet A, Damotte D, Wislez M, Alifano M et al (2023) Impact of sarcopenia indexes on survival and severe immune acute toxicity in metastatic non-small cell lung cancer patients treated with PD-1 immune checkpoint inhibitors. Clin Nutr (edinburgh, Scotland) 42(6):944–953
go back to reference Avgerinos KI, Spyrou N, Mantzoros CS, Dalamaga M (2019) Obesity and cancer risk: emerging biological mechanisms and perspectives. Metabolism 92:121–135PubMed Avgerinos KI, Spyrou N, Mantzoros CS, Dalamaga M (2019) Obesity and cancer risk: emerging biological mechanisms and perspectives. Metabolism 92:121–135PubMed
go back to reference Barbi J, Patnaik SK, Pabla S, Zollo R et al (2021) Visceral obesity promotes lung cancer progression-toward resolution of the obesity paradox in lung cancer. J Thorac Oncol 16(8):1333–1348PubMedPubMedCentral Barbi J, Patnaik SK, Pabla S, Zollo R et al (2021) Visceral obesity promotes lung cancer progression-toward resolution of the obesity paradox in lung cancer. J Thorac Oncol 16(8):1333–1348PubMedPubMedCentral
go back to reference Buckley E, Mullen MM, Nizamuddin RA, Stein JH, Kuroki LM, Fuh KC, Hagemann AR, McCourt CK, Mutch D, Khabele D et al (2022) High visceral fat to subcutaneous fat ratios portend a poor prognosis in patients with advanced endometrial cancer. Gynecol Oncol 167(3):496–501PubMedPubMedCentral Buckley E, Mullen MM, Nizamuddin RA, Stein JH, Kuroki LM, Fuh KC, Hagemann AR, McCourt CK, Mutch D, Khabele D et al (2022) High visceral fat to subcutaneous fat ratios portend a poor prognosis in patients with advanced endometrial cancer. Gynecol Oncol 167(3):496–501PubMedPubMedCentral
go back to reference Collet L, Delrieu L, Bouhamama A, Crochet H, Swalduz A, Nerot A, Marchal T, Chabaud S, Heudel PE (2021) Association between body mass index and survival outcome in metastatic cancer patients treated by immunotherapy: analysis of a french retrospective cohort. Cancers (basel) 13(9):2200PubMed Collet L, Delrieu L, Bouhamama A, Crochet H, Swalduz A, Nerot A, Marchal T, Chabaud S, Heudel PE (2021) Association between body mass index and survival outcome in metastatic cancer patients treated by immunotherapy: analysis of a french retrospective cohort. Cancers (basel) 13(9):2200PubMed
go back to reference Cortellini A, Ricciuti B, Tiseo M, Bria E, Banna GL, Aerts JG, Barbieri F, Giusti R, Cortinovis DL, Migliorino MR et al (2020) Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression >/= 50%: a multicenter study with external validation. J Immunother Cancer 8(2):e001403PubMedPubMedCentral Cortellini A, Ricciuti B, Tiseo M, Bria E, Banna GL, Aerts JG, Barbieri F, Giusti R, Cortinovis DL, Migliorino MR et al (2020) Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression >/= 50%: a multicenter study with external validation. J Immunother Cancer 8(2):e001403PubMedPubMedCentral
go back to reference Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman JR, Bharat A, Bruno DS, Chang JY, Chirieac LR, DeCamp M et al (2023) NCCN Guidelines(R) insights: non-small cell lung cancer, version 2.2023. J Natl Compr Canc Netw 21(4):340–350PubMed Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman JR, Bharat A, Bruno DS, Chang JY, Chirieac LR, DeCamp M et al (2023) NCCN Guidelines(R) insights: non-small cell lung cancer, version 2.2023. J Natl Compr Canc Netw 21(4):340–350PubMed
go back to reference Font-Burgada J, Sun B, Karin M (2016) Obesity and cancer: the oil that feeds the flame. Cell Metab 23(1):48–62PubMed Font-Burgada J, Sun B, Karin M (2016) Obesity and cancer: the oil that feeds the flame. Cell Metab 23(1):48–62PubMed
go back to reference Frasca D, Diaz A, Romero M, Thaller S, Blomberg BB (2018) Secretion of autoimmune antibodies in the human subcutaneous adipose tissue. PLoS ONE 13(5):e0197472PubMedPubMedCentral Frasca D, Diaz A, Romero M, Thaller S, Blomberg BB (2018) Secretion of autoimmune antibodies in the human subcutaneous adipose tissue. PLoS ONE 13(5):e0197472PubMedPubMedCentral
go back to reference Friedenreich CM, Ryder-Burbidge C, McNeil J (2021) Physical activity, obesity and sedentary behavior in cancer etiology: epidemiologic evidence and biologic mechanisms. Mol Oncol 15(3):790–800PubMed Friedenreich CM, Ryder-Burbidge C, McNeil J (2021) Physical activity, obesity and sedentary behavior in cancer etiology: epidemiologic evidence and biologic mechanisms. Mol Oncol 15(3):790–800PubMed
go back to reference Gezer NS, Bandos AI, Beeche CA, Leader JK, Dhupar R, Pu J (2023) CT-derived body composition associated with lung cancer recurrence after surgery. Lung Cancer 179:107189PubMed Gezer NS, Bandos AI, Beeche CA, Leader JK, Dhupar R, Pu J (2023) CT-derived body composition associated with lung cancer recurrence after surgery. Lung Cancer 179:107189PubMed
go back to reference Gomez-Perez SL, Haus JM, Sheean P, Patel B, Mar W, Chaudhry V, McKeever L, Braunschweig C (2016) Measuring abdominal circumference and skeletal muscle from a single cross-sectional computed tomography image: a step-by-step guide for clinicians using National Institutes of Health ImageJ. JPEN J Parenter Enteral Nutr 40(3):308–318PubMed Gomez-Perez SL, Haus JM, Sheean P, Patel B, Mar W, Chaudhry V, McKeever L, Braunschweig C (2016) Measuring abdominal circumference and skeletal muscle from a single cross-sectional computed tomography image: a step-by-step guide for clinicians using National Institutes of Health ImageJ. JPEN J Parenter Enteral Nutr 40(3):308–318PubMed
go back to reference Gonzalez MC, Pastore CA, Orlandi SP, Heymsfield SB (2014) Obesity paradox in cancer: new insights provided by body composition. Am J Clin Nutr 99(5):999–1005PubMed Gonzalez MC, Pastore CA, Orlandi SP, Heymsfield SB (2014) Obesity paradox in cancer: new insights provided by body composition. Am J Clin Nutr 99(5):999–1005PubMed
go back to reference He K, Si L, Pan X, Sun L, Wang Y, Lu J, Wang X (2022) Preoperative systemic immune-inflammation index (SII) as a superior predictor of long-term survival outcome in patients with stage I–II gastric cancer after radical surgery. Front Oncol 12:829689PubMedPubMedCentral He K, Si L, Pan X, Sun L, Wang Y, Lu J, Wang X (2022) Preoperative systemic immune-inflammation index (SII) as a superior predictor of long-term survival outcome in patients with stage I–II gastric cancer after radical surgery. Front Oncol 12:829689PubMedPubMedCentral
go back to reference Hervochon R, Bobbio A, Guinet C (2017) Body mass index and total psoas area affect outcomes in patients undergoing pneumonectomy for cancer. Ann Thorac Surg 103(1):287–295PubMed Hervochon R, Bobbio A, Guinet C (2017) Body mass index and total psoas area affect outcomes in patients undergoing pneumonectomy for cancer. Ann Thorac Surg 103(1):287–295PubMed
go back to reference Karra P, Winn M, Pauleck S, Bulsiewicz-Jacobsen A, Peterson L, Coletta A (2022) Metabolic dysfunction and obesity-related cancer: beyond obesity and metabolic syndrome. Obesity (silver Spring) 30(7):1323–1334PubMed Karra P, Winn M, Pauleck S, Bulsiewicz-Jacobsen A, Peterson L, Coletta A (2022) Metabolic dysfunction and obesity-related cancer: beyond obesity and metabolic syndrome. Obesity (silver Spring) 30(7):1323–1334PubMed
go back to reference Kim JM, Chung E, Cho ES, Lee JH, Shin SJ, Lee HS (2021) Impact of subcutaneous and visceral fat adiposity in patients with colorectal cancer. Clin Nutr 40(11):5631–5638PubMed Kim JM, Chung E, Cho ES, Lee JH, Shin SJ, Lee HS (2021) Impact of subcutaneous and visceral fat adiposity in patients with colorectal cancer. Clin Nutr 40(11):5631–5638PubMed
go back to reference Kirshenboim Z, Lantsman CD, Appel S, Klug M, Onn A, Truong MT, Marom EM (2023) Magnetic resonance imaging for prospective assessment of local recurrence of non-small cell lung cancer after stereotactic body radiation therapy. Lung Cancer 182:107265PubMed Kirshenboim Z, Lantsman CD, Appel S, Klug M, Onn A, Truong MT, Marom EM (2023) Magnetic resonance imaging for prospective assessment of local recurrence of non-small cell lung cancer after stereotactic body radiation therapy. Lung Cancer 182:107265PubMed
go back to reference Laird BJ, Kaasa S, McMillan DC, Fallon MT, Hjermstad MJ, Fayers P, Klepstad P (2013) Prognostic factors in patients with advanced cancer: a comparison of clinicopathological factors and the development of an inflammation-based prognostic system. Clin Cancer Res 19(19):5456–5464PubMed Laird BJ, Kaasa S, McMillan DC, Fallon MT, Hjermstad MJ, Fayers P, Klepstad P (2013) Prognostic factors in patients with advanced cancer: a comparison of clinicopathological factors and the development of an inflammation-based prognostic system. Clin Cancer Res 19(19):5456–5464PubMed
go back to reference Lalani AK, Xie W, Martini DJ, Steinharter JA, Norton CK, Krajewski KM, Duquette A, Bossé D, Bellmunt J, Van Allen EM, McGregor BA et al (2018) Change in Neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma. J Immunother Cancer 6(1):5PubMedPubMedCentral Lalani AK, Xie W, Martini DJ, Steinharter JA, Norton CK, Krajewski KM, Duquette A, Bossé D, Bellmunt J, Van Allen EM, McGregor BA et al (2018) Change in Neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma. J Immunother Cancer 6(1):5PubMedPubMedCentral
go back to reference Lee JS, Lee HS, Ha JS, Han KS, Rha KH, Hong SJ, Chung BH, Koo KC (2018) Subcutaneous fat distribution is a prognostic biomarker for men with castration resistant prostate cancer. J Urol 200(1):114–120PubMed Lee JS, Lee HS, Ha JS, Han KS, Rha KH, Hong SJ, Chung BH, Koo KC (2018) Subcutaneous fat distribution is a prognostic biomarker for men with castration resistant prostate cancer. J Urol 200(1):114–120PubMed
go back to reference Lee JH, Yoon YC, Kim HS, Cha MJ, Kim JH, Kim K, Kim HS (2022) Obesity is associated with improved postoperative overall survival, independent of skeletal muscle mass in lung adenocarcinoma. J Cachexia, Sarcopenia Muscle 13(2):1076–1086PubMed Lee JH, Yoon YC, Kim HS, Cha MJ, Kim JH, Kim K, Kim HS (2022) Obesity is associated with improved postoperative overall survival, independent of skeletal muscle mass in lung adenocarcinoma. J Cachexia, Sarcopenia Muscle 13(2):1076–1086PubMed
go back to reference Liu J, Li S, Zhang S, Liu Y, Ma L, Zhu J, Xin Y, Wang Y, Yang C, Cheng Y (2019) Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab. J Clin Lab Anal 33(8):e22964PubMedPubMedCentral Liu J, Li S, Zhang S, Liu Y, Ma L, Zhu J, Xin Y, Wang Y, Yang C, Cheng Y (2019) Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab. J Clin Lab Anal 33(8):e22964PubMedPubMedCentral
go back to reference Nitsche L, Vedire Y, Kannisto E, Wang X, Seager RJ, Pabla S, Patnaik SK, Yendamuri S (2022) Visceral obesity in non-small cell lung cancer. Cancers (basel) 14(14):3450PubMed Nitsche L, Vedire Y, Kannisto E, Wang X, Seager RJ, Pabla S, Patnaik SK, Yendamuri S (2022) Visceral obesity in non-small cell lung cancer. Cancers (basel) 14(14):3450PubMed
go back to reference Nøst TH, Alcala K, Urbarova I, Byrne KS, Guida F, Sandanger TM, Johansson M (2021) Systemic inflammation markers and cancer incidence in the UK Biobank. Eur J Epidemiol 36(8):841–848PubMedPubMedCentral Nøst TH, Alcala K, Urbarova I, Byrne KS, Guida F, Sandanger TM, Johansson M (2021) Systemic inflammation markers and cancer incidence in the UK Biobank. Eur J Epidemiol 36(8):841–848PubMedPubMedCentral
go back to reference Prado CMM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, Baracos VE (2008) Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 9(7):629–635PubMed Prado CMM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, Baracos VE (2008) Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 9(7):629–635PubMed
go back to reference Russo A, Russano M, Franchina T, Migliorino MR, Aprile G, Mansueto G, Berruti A, Falcone A, Aieta M, Gelibter A, Russo A et al (2020) Neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and outcomes with nivolumab in pretreated non-small cell lung cancer (NSCLC): a large retrospective multicenter study. Adv Ther 37(3):1145–1155PubMed Russo A, Russano M, Franchina T, Migliorino MR, Aprile G, Mansueto G, Berruti A, Falcone A, Aieta M, Gelibter A, Russo A et al (2020) Neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and outcomes with nivolumab in pretreated non-small cell lung cancer (NSCLC): a large retrospective multicenter study. Adv Ther 37(3):1145–1155PubMed
go back to reference Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9(7):671–675PubMedPubMedCentral Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9(7):671–675PubMedPubMedCentral
go back to reference Shao F, Chen Y, Xu H, Chen X, Zhou J, Wu Y, Tang Y, Wang Z, Zhang R, Lange T et al (2022) Metabolic obesity phenotypes and risk of lung cancer: a prospective cohort study of 450,482 UK Biobank Participants. Nutrients 14(16):3370PubMedPubMedCentral Shao F, Chen Y, Xu H, Chen X, Zhou J, Wu Y, Tang Y, Wang Z, Zhang R, Lange T et al (2022) Metabolic obesity phenotypes and risk of lung cancer: a prospective cohort study of 450,482 UK Biobank Participants. Nutrients 14(16):3370PubMedPubMedCentral
go back to reference Siegel RL, Miller KD, Jemal A (2023) Cancer statistics, 2023. CA Cancer J Clin 73(1):17–48PubMed Siegel RL, Miller KD, Jemal A (2023) Cancer statistics, 2023. CA Cancer J Clin 73(1):17–48PubMed
go back to reference Silveira EA, Kliemann N, Noll M, Sarrafzadegan N, de Oliveira C (2021) Visceral obesity and incident cancer and cardiovascular disease: an integrative review of the epidemiological evidence. Obes Rev 22(1):e13088PubMed Silveira EA, Kliemann N, Noll M, Sarrafzadegan N, de Oliveira C (2021) Visceral obesity and incident cancer and cardiovascular disease: an integrative review of the epidemiological evidence. Obes Rev 22(1):e13088PubMed
go back to reference Spoto B, Di Betta E, Mattace-Raso F, Sijbrands E et al (2014) Pro- and anti-inflammatory cytokine gene expression in subcutaneous and visceral fat in severe obesity. Nutr Metab Cardiovasc Dis 24(10):1137–1143PubMed Spoto B, Di Betta E, Mattace-Raso F, Sijbrands E et al (2014) Pro- and anti-inflammatory cytokine gene expression in subcutaneous and visceral fat in severe obesity. Nutr Metab Cardiovasc Dis 24(10):1137–1143PubMed
go back to reference Spoto B, Di Betta E, Pizzini P, Lonardi S et al (2023) Inflammation biomarkers and inflammatory genes expression in metabolically healthy obese patients. Nutr Metab Cardiovasc Dis 33(3):584–591PubMed Spoto B, Di Betta E, Pizzini P, Lonardi S et al (2023) Inflammation biomarkers and inflammatory genes expression in metabolically healthy obese patients. Nutr Metab Cardiovasc Dis 33(3):584–591PubMed
go back to reference Tabuso M, Homer-Vanniasinkam S, Adya R, Arasaradnam RP (2017) Role of tissue microenvironment resident adipocytes in colon cancer. World J Gastroenterol 23(32):5829–5835PubMedPubMedCentral Tabuso M, Homer-Vanniasinkam S, Adya R, Arasaradnam RP (2017) Role of tissue microenvironment resident adipocytes in colon cancer. World J Gastroenterol 23(32):5829–5835PubMedPubMedCentral
go back to reference Thai AA, Solomon BJ, Sequist LV (2021) Lung cancer. Lancet (lond, Engl) 398(10299):535–554 Thai AA, Solomon BJ, Sequist LV (2021) Lung cancer. Lancet (lond, Engl) 398(10299):535–554
go back to reference van Vugt JL, Levolger S, Gharbharan A, Koek M, Niessen WJ, Burger JW, Willemsen SP, de Bruin RW, Ijzermans JN (2017) A comparative study of software programmes for cross-sectional skeletal muscle and adipose tissue measurements on abdominal computed tomography scans of rectal cancer patients. J Cachexia Sarcopenia Muscle 8(2):285–297PubMed van Vugt JL, Levolger S, Gharbharan A, Koek M, Niessen WJ, Burger JW, Willemsen SP, de Bruin RW, Ijzermans JN (2017) A comparative study of software programmes for cross-sectional skeletal muscle and adipose tissue measurements on abdominal computed tomography scans of rectal cancer patients. J Cachexia Sarcopenia Muscle 8(2):285–297PubMed
go back to reference Voorn MJ, Beukers K, Trepels CM, Bootsma GP, Bongers BC, Janssen-Heijnen ML (2022) Associations between pretreatment nutritional assessments and treatment complications in patients with stage I–III non-small cell lung cancer: a systematic review. Clin Nutr ESPEN 47:152–162PubMed Voorn MJ, Beukers K, Trepels CM, Bootsma GP, Bongers BC, Janssen-Heijnen ML (2022) Associations between pretreatment nutritional assessments and treatment complications in patients with stage I–III non-small cell lung cancer: a systematic review. Clin Nutr ESPEN 47:152–162PubMed
go back to reference Wang Y, Li Y, Chen P, Xu W, Wu Y, Che G (2019a) Prognostic value of the pretreatment systemic immune-inflammation index (SII) in patients with non-small cell lung cancer: a meta-analysis. Ann Transl Med 7(18):433PubMedPubMedCentral Wang Y, Li Y, Chen P, Xu W, Wu Y, Che G (2019a) Prognostic value of the pretreatment systemic immune-inflammation index (SII) in patients with non-small cell lung cancer: a meta-analysis. Ann Transl Med 7(18):433PubMedPubMedCentral
go back to reference Wang Z, Aguilar EG, Luna JI, Dunai C, Khuat LT, Le CT, Mirsoian A, Minnar CM, Stoffel KM et al (2019b) Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade. Nat Med 25(1):141–151PubMed Wang Z, Aguilar EG, Luna JI, Dunai C, Khuat LT, Le CT, Mirsoian A, Minnar CM, Stoffel KM et al (2019b) Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade. Nat Med 25(1):141–151PubMed
go back to reference Wang HK, Wei Q, Yang YL, Lu TY, Yan Y, Wang F (2023) Clinical usefulness of the lymphocyte-to-monocyte ratio and aggregate index of systemic inflammation in patients with esophageal cancer: a retrospective cohort study. Cancer Cell Int 23(1):13PubMedPubMedCentral Wang HK, Wei Q, Yang YL, Lu TY, Yan Y, Wang F (2023) Clinical usefulness of the lymphocyte-to-monocyte ratio and aggregate index of systemic inflammation in patients with esophageal cancer: a retrospective cohort study. Cancer Cell Int 23(1):13PubMedPubMedCentral
Metadata
Title
Influence of abdominal fat distribution and inflammatory status on post-operative prognosis in non-small cell lung cancer patients: a retrospective cohort study
Authors
Mengtian Ma
Muqing Luo
Qianyun Liu
Dong Zhong
Yinqi Liu
Kun Zhang
Publication date
01-03-2024
Publisher
Springer Berlin Heidelberg
Published in
Journal of Cancer Research and Clinical Oncology / Issue 3/2024
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-024-05633-5

Other articles of this Issue 3/2024

Journal of Cancer Research and Clinical Oncology 3/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.